Jonathan Rivnay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MI Europe Announces InnoLAE 2024 Event

In 2021, a Northwestern University-led research team received a Defense Advanced Research Projects Agency (DARPA) contract worth up to $33 million to develop an implantable "living pharmacy" to control the human body's sleep/wake cycles.

<p>Researchers have developed a novel device that produces oxygen inside of a &quot;living pharmacy&quot; implant in order to keep cells alive inside the self-contained device. The device produses oxygen through a&nbsp;smart, energy-efficient version of water splitting.&nbsp;In new experiments, the novel device&nbsp;kept cells (70-80%) alive for close to a month in low oxygen conditions in vitro, or weeks in vivo. Without ecO₂, only about 20% of cells were alive after 10 days, but the researchers hypothesize that the cells would lose their abili...

The Advanced Research Projects Agency for Health awarded researchers at Northwestern and seven other institutions a $45 million grant to continue developing a small, implantable device that could detect and treat cancer, NU announced Tuesday. The multi-institutional effort is funded by the agency, which aims to fast-track novel cancer technologies. The Biden-Harris administration recently pledged...

Researchers could use the technology to create stronger biosensors that can read signals within the body to collect more accurate diagnostic & treatment data.